60 Degrees Pharmaceuticals, Inc.
Washington, DC Doing business as 60P
- UEI
- WKN5DNLTVF95
- CAGE
- 71D06
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1025 Connecticut Ave NW #1000, Washington, DC 20036, USA
- Website
- 60degreespharma.com
- Founded
- 2010
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$28,966 |
| FY2024 | $311,862 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Arakoda (TAFENQUINE) commercial packaging and validation | Defense Health Agency | $311,862 | |
| "covid-19" prototype tefonequine | ACC Aberdeen Proving Ground | $5,719,814 | |
| Brand name arakoda malaria prophylactic drug tafenoquine | Defense Health Agency | $5,473,597 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Amivas US LLC | Frederick, MD | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Rigel Pharmaceuticals Inc. | South San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Cipla USA Inc. | Warren, NJ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Amgen Inc. | Thousand Oaks, CA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical corporation that develops and commercializes infectious disease medicines for COVID-19, malaria, dengue, and other diseases. As a manufacturer of pharmaceutical goods, it has received federal contracts from Department of Defense and Veterans Affairs agencies to supply drug products.
Through a $5.7 million other transaction agreement with the Department of the Army's Acquisition Support Center, 60 Degrees Pharmaceuticals is developing a COVID-19 treatment involving prototype equine antibodies. It also has a $6 million definitive contract from the Army Medical Command for its Arakoda brand malaria prophylactic drug Tafenoquine. Both awards are prime contracts with no set aside designations or subcontractors.
The company holds two Federal Supply Schedule indefinite delivery vehicles from Veterans Affairs to provide pharmaceuticals and hematology supplies under GSA Schedule 65IB. The first is a 5-year, $250,000 multiple award IDV enabling VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The second is a $25,000 interim scheduling agreement with the same network for drugs and pharmaceuticals. As blanket purchasing agreements against which customer agencies can place task orders, these IDVs streamline VA drug procurement for veteran healthcare programs.
Quick answers
Is 60 Degrees Pharmaceuticals, Inc. registered in SAM.gov?
Yes. 60 Degrees Pharmaceuticals, Inc.'s SAM.gov registration is active through April 15, 2027.
What is 60 Degrees Pharmaceuticals, Inc.'s CAGE code?
60 Degrees Pharmaceuticals, Inc.'s CAGE code is 71D06, and its Unique Entity ID (UEI) is WKN5DNLTVF95.
Which contract vehicles does 60 Degrees Pharmaceuticals, Inc. hold?
60 Degrees Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has 60 Degrees Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $282,896 to 60 Degrees Pharmaceuticals, Inc. in fiscal years 2023 through 2027.
What is 60 Degrees Pharmaceuticals, Inc.'s most recent federal award?
60 Degrees Pharmaceuticals, Inc.'s most recent federal contract award is Arakoda (TAFENQUINE) commercial packaging and validation (HT942524C0038), from Defense Health Agency, on July 24, 2024.
On GovTribe
See 60 Degrees Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors